期刊文献+

(1R,2R)-1,2-环己烷二甲醇二甲磺酸酯的合成 被引量:1

Synthesis of(1R,2R)-1,2-dimethyl Cyclohexane Dimethanol Sulfonate
原文传递
导出
摘要 目的:合成(1R,2R)-1,2-环己烷二甲醇二甲磺酸酯(化合物1)。方法:以(±)-反式-4-环己烯-1,2-二甲酸(化合物2)为原料,经钯碳还原、(R)-1-苯乙胺拆分、在甲醇中与氯化亚砜反应、硼氢化钠-无水氯化锂还原、甲基磺酰氯反应得到目标化合物,并进行核磁共振(1H-NMR)或质谱(MS)表征。以(1R,2R)-1,2-环己烷二甲酸(化合物4)/氯化亚砜的投料比、反应温度和时间对酰化反应进行优化,以化合物4/硼氢化钠/无水氯化锂的投料比、反应温度和时间、溶剂对酯还原反应进行优化,筛选(1R,2R)-1,2-环己烷二甲醇(化合物5)的合成条件。结果:表征确证目标化合物为化合物1,总收率为27.9%,纯度>99%。化合物5的合成中,酰化反应条件为化合物4/氯化亚砜投料比为1.0:2.2,反应温度为65℃,反应时间为2h;酯还原反应条件为化合物4/硼氢化钾/无水氯化锂投料比为1.0:3.0:3.0,反应温度为20~30℃,反应时间为24h,溶剂为四氢呋喃。结论:所建立的反应条件温和、操作简便易行,各步原料价格低廉。 OBJECTIVE:To synthetize(1R,2R)-1,2-dimethyl cyclohexane dimethanol sulfonate(compound 1).METHODS:The target compound was synthesized from trans-4-cyclohexene-1,2-dicarboxylic acid(compound 2),through reduced by Pd/C,separated by(R)-1-phenethylamine,reacted with thionyl chloride in methanol,reduced by sodium borohydride-anhydrous lithium chloride and then reacted with methylsufonyl chloride.The target compound was characterized by MS or 1 H-NMR.The acylation reaction was optimized by ratio of thionyl chloride to(1R,2R)-1,2-cyclohexane dicarboxylic acid(compound 4),reaction temperature and reaction time.The ester reduction reaction was optimized by ratio of compound 4 to sodium borohydride to anhydrous lithium chloride,reaction temperature and time,solvent.The synthesis condition was screened for(1R,2R)-1,2-cyclohexane dimethanol(compound 5).RESULTS:The target compound was confirmed as compound 1,with total yield of 27.9% and purity of 99%.The synthesis condition of compound 5 was as follows:acylation with ratio of compound 4 to thionyl chloride as 1.0:2.2,reaction temperature of 65 ℃,reaction time of 2 h;ester reduction with ratio of compound 4 to potassium borohydride to anhydrous lithium chloride as 1.0:3.0:3.0,reaction temperature of 20-30 ℃,reaction time of 24 h,solvent of diethylene oxide.CONCLUSIONS:The synthesis process is mild in reaction conditions and simple in operation.Raw materials of each step cost less.
出处 《中国药房》 CAS CSCD 2013年第29期2713-2715,共3页 China Pharmacy
关键词 (1R 2R)-1 2-环己烷二甲醇二甲磺酸酯 拆分 合成 (1R 2R)-1 2-dimethyl cyclohexane dimethanol sulfonate Resolution Synthesis
  • 相关文献

参考文献10

  • 1杨臻峥,孙大柠.抗精神病药Lurasidone Hydrochloride[J].药学进展,2009,33(2):91-93. 被引量:14
  • 2封宇飞.抗精神病新药鲁拉西酮的药理与临床研究进展[J].中国新药杂志,2011,20(10):853-856. 被引量:8
  • 3曹运莉,朱珠.新型抗精神分裂症药物鲁拉西酮[J].药物流行病学杂志,2011,20(5):257-260. 被引量:2
  • 4严寒,刘津爱,王明新,等.一种制备鲁拉西酮的方法:中国.102827157A[P].2012-12-19.
  • 5Goodridge RJ, Hambley TW, Ridley DD. Preparations and crystal structures of the 2-oxides of some octahydro-3,2, 1-benzoxathiazines and octahydro-2h-3, 1, 2-benzoxaza-phosphorines[J]. Aust J Chem, 1986,39(4) : 591.
  • 6William JB, Harold RG. Cyclic dienes I 1, 2-dimethylen- ecyclohexane[J]. JAm Chem Soc, 1953,75 (19) :4 780.
  • 7Berkessel A, Glaubitz K, Lex J. Enantiomerically pure fl- amino acids: a convenient access to both enantiomers of trans-2-aminocyclohexanecarboxylic acid[J]. Eur d Org Chem,2002(17) :2 948.
  • 8娄玲珠,张海军,郑淑亚.1R,2R-1,2-环己二甲酸合成工艺改进[J].大科技,2012(9):349-350. 被引量:1
  • 9Longeau A, Durand S, Spiegel A, et al. Synthesis of new C2-syrnmetrical diphosphines using chiral zinc organome- tallies [J]. Tetrahedron: Asymmetry, 1997,8 (7) : 987.
  • 10Muto M, Ikutaro S, Tanno N, et al. Imide derivatives, and their production and use: US, 5532372[P]. 1996-07-02.

二级参考文献22

  • 1United States Food and Drug Administration. FDA approves Latuda to treat schizophrenia in adults[ EB/OL]. http:// www. fda. gov/NewsEvents/Newsroom/PressAnrtouncements/ ucm231512.htm, 2010-10-28/2011-03-18.
  • 2United States Food and Drug Administration. Label approved on 12/10/2010 (PDF) for LATUDA [ EB/OL]. http:// www. accessdata.fda. gov/drugsatfda_ docs/label/2010/ 200603s001lbl. pdf.
  • 3Ishibashi T, Horisawa T, Tokuda K, et al. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activ- ity[J]. J Pharmacol Exp Ther, 2010, 334( 1 ) : 171-181.
  • 4Meneses A. Effects of the 5-HT7 receptor antagonists SB- 269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task[J]. Behav Brain Re, 2004. 155(2) : 275-282.
  • 5Nakamura M, Ogasa M, Guarino J, et al. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo- controlled trial[J]. J Clin Psychiatry, 2009, 70(6) : 829- 836.
  • 6Dainippon Sumitomo Pharma America, Inc. Lurasidone De- monstrated Efficacy in Treating Patients with Schizophrenia in Pivotal Phase 3 Study [ EB/OL]. http ://www. sunovion. com/news/pressReleases-dspa/20090826. pdf, 2009-08-26/ 2011-03-18.
  • 7Studies with search of Lurasidone[ EB/OL]. http ://clinical- trials. gov/ct2/results? term = lurasidone&pg = 1,2011-03- 16/2011-03-18.
  • 8Citrome L. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic [ J ]. Clin Schizophr Re- lat Psychoses, 2011 , 4(4) :251-257.
  • 9Citrome L. Lurasidone for schizophrenia: a review of the ef- ficacy and safety profile for this newly approved second-gen- eration antipsychotic [ J ]. Int J Clin Pract, 2010,64 : 1742.
  • 10Cucchiaro J, Pikalov A, Ogasa M, et al. Safety of lurasi- done: pooled analysis of five placebo-controlled trials in pa- tients with schizophrenia(abstract) [EB/OL]. http://www. cmelle. com/psycheongress/ , 2010-11-20/2011-03-18.

共引文献19

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部